Related references
Note: Only part of the references are listed.The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
Zuzana Kolkova et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer
Yoshimichi Tanaka et al.
CANCER BIOLOGY & THERAPY (2011)
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27
Hiroaki Itamochi et al.
GYNECOLOGIC ONCOLOGY (2011)
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Hugo Arias-Pulido et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers
Satoshi Tsunetoh et al.
CANCER BIOLOGY & THERAPY (2010)
Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
Yin-Yan He et al.
CANCER SCIENCE (2009)
Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Deo Prakash Pandey et al.
EMBO JOURNAL (2009)
GPR30 predicts poor survival for ovarian cancer
Harriet O. Smith et al.
GYNECOLOGIC ONCOLOGY (2009)
被撤回的出版物: G-Protein-Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells (Retracted article. See vol. 122, pg. A42, 2014)
Lidia Albanito et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
17-β-Estradiol Inhibits Transforming Growth Factor-β Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30
Burkhard Kleuser et al.
MOLECULAR PHARMACOLOGY (2008)
Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer
Rui-Xia Guo et al.
PATHOLOGY INTERNATIONAL (2008)
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells
Lidia Albanito et al.
CANCER RESEARCH (2007)
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
Edward J. Filardo et al.
CLINICAL CANCER RESEARCH (2006)
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa et al.
NATURE CHEMICAL BIOLOGY (2006)
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer
A Psyrri et al.
CLINICAL CANCER RESEARCH (2005)
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells
M Maggiolini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Menopausal hormone replacement therapy and risk of ovarian cancer
JV Lacey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: Systematic review of the literature and implications for future research
JL Perez-Gracia et al.
GYNECOLOGIC ONCOLOGY (2002)
Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer
EJ Filardo
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
The multifaceted mechanisms of estradiol and estrogen receptor signaling
JM Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
C Rodriguez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
EJ Filardo et al.
MOLECULAR ENDOCRINOLOGY (2000)
Chemical interference with genomic and nongenomic actions of steroids in fishes: role of receptor binding
P Thomas
MARINE ENVIRONMENTAL RESEARCH (2000)
Absence of estrogen receptor-beta expression in metastatic ovarian cancer
T Rutherford et al.
OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
